{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T06:56:44Z","timestamp":1775804204390,"version":"3.50.1"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Transplant."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatocellular carcinoma (HCC) incidence and mortality are rising. Liver transplantation (LT) offers the best outcomes, but current tumor size- and number-based selection criteria restrict access. Molecular profiling may better reflect tumor biology and guide precision-based selection strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective single-center study included patients with HCC who had undergone LT between 11 November 2016 and 4 April 2023 with sufficient tumor cellularity in explanted livers. Tumor DNA was subjected to targeted sequencing for 38 genes, with the results returned to clinicians. Altered genes were grouped into HCC-relevant signaling pathways. Outcomes included post-LT overall survival (OS), recurrence-free survival (RFS), and recurrence sites. The Cancer Genome Atlas (TCGA) HCC cohort was used for validation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 1,103 LT recipients, 261 were for HCC and 91 underwent sequencing. Most patients were male (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200968), white (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200956), and hepatitis C positive (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200934). The median tumor size was 3\u2005cm (IQR 1.8\u20134.5), the number was 1 (IQR 1\u20133), and the follow-up time was 1,982 days. Of the 36 unique mutations found across 11 genes, six were potentially actionable. Cell cycle pathway alterations (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200914) were prognostic for worse OS (3-year 90.9% without vs. 62.5% with alterations) and RFS in uni- and multivariable models. Recurrences were more common in the liver and lungs with cell cycle alterations (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Post-LT molecular profiling of HCC reveals tumor-specific alterations associated with outcomes, supporting the incorporation of tumor biology into future LT selection criteria.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/frtra.2026.1758576","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T06:01:23Z","timestamp":1775800883000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Cell cycle pathway alterations predict outcomes post-liver transplantation for hepatocellular carcinoma"],"prefix":"10.3389","volume":"5","author":[{"given":"Ashton A.","family":"Connor","sequence":"first","affiliation":[{"name":"Department of Surgery, Houston Methodist Hospital","place":["Houston, TX, United States"]},{"name":"JC Walter Jr Transplant Center, Houston Methodist Hospital","place":["Houston, TX, United States"]},{"name":"Department of Surgery, Weill Cornell Medical College","place":["New York, NY, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahinur","family":"Mattohti","sequence":"additional","affiliation":[{"name":"Immunobiology and Transplant Science Center, Houston Methodist Research Institute, Houston Methodist Hospital","place":["Houston, TX, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudha","family":"Kodali","sequence":"additional","affiliation":[{"name":"JC Walter Jr Transplant Center, Houston Methodist Hospital","place":["Houston, TX, United States"]},{"name":"Sherrie and Alan Conover Center for Liver Disease and Transplantation, Houston Methodist Hospital","place":["Houston, TX, United States"]},{"name":"Department of Medicine, Weill Cornell Medical College","place":["New York, NY, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maen","family":"Abdelrahim","sequence":"additional","affiliation":[{"name":"Department of Medicine, Weill Cornell Medical College","place":["New York, NY, United States"]},{"name":"Department of Medical Oncology, Houston Methodist Cancer Center","place":["Houston, TX, United States"]},{"name":"Cockrell Center Phase 1 Unit, Cockrell Center for Advanced Therapeutics, Houston Methodist Hospital","place":["Houston, TX, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Elaileh","sequence":"additional","affiliation":[{"name":"Department of Surgery, Houston Methodist Hospital","place":["Houston, TX, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samar","family":"Semaan","sequence":"additional","affiliation":[{"name":"Department of Surgery, Houston Methodist Hospital","place":["Houston, TX, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youssef","family":"Dib","sequence":"additional","affiliation":[{"name":"Department of Surgery, Houston Methodist Hospital","place":["Houston, TX, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khush","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Surgery, Houston Methodist Hospital","place":["Houston, TX, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Todd","sequence":"additional","affiliation":[{"name":"Department of Surgery, Houston Methodist Hospital","place":["Houston, TX, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urmi","family":"Sengupta","sequence":"additional","affiliation":[{"name":"Department of Surgery, Houston Methodist Hospital","place":["Houston, TX, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constance M.","family":"Mobley","sequence":"additional","affiliation":[{"name":"Department of Surgery, Houston Methodist Hospital","place":["Houston, TX, United States"]},{"name":"JC Walter Jr Transplant Center, Houston Methodist Hospital","place":["Houston, TX, United States"]},{"name":"Department of Surgery, Weill Cornell Medical College","place":["New York, NY, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline J.","family":"Simon","sequence":"additional","affiliation":[{"name":"Department of Surgery, Houston Methodist Hospital","place":["Houston, TX, United States"]},{"name":"JC Walter Jr Transplant Center, Houston Methodist Hospital","place":["Houston, TX, United States"]},{"name":"Department of Surgery, Weill Cornell Medical College","place":["New York, NY, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yee Lee","family":"Cheah","sequence":"additional","affiliation":[{"name":"Department of Surgery, Houston Methodist Hospital","place":["Houston, TX, United States"]},{"name":"JC Walter Jr Transplant Center, Houston Methodist Hospital","place":["Houston, TX, United States"]},{"name":"Department of Surgery, Weill Cornell Medical College","place":["New York, NY, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish","family":"Saharia","sequence":"additional","affiliation":[{"name":"Department of Surgery, Houston Methodist Hospital","place":["Houston, TX, United States"]},{"name":"JC Walter Jr Transplant Center, Houston Methodist Hospital","place":["Houston, TX, United States"]},{"name":"Department of Surgery, Weill Cornell Medical College","place":["New York, NY, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary R.","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Cockrell Center Phase 1 Unit, Cockrell Center for Advanced Therapeutics, Houston Methodist Hospital","place":["Houston, TX, United States"]},{"name":"Department of Pathology and Genomic Medicine, Houston Methodist Hospital","place":["Houston, TX, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadhna","family":"Dhingra","sequence":"additional","affiliation":[{"name":"Cockrell Center Phase 1 Unit, Cockrell Center for Advanced Therapeutics, Houston Methodist Hospital","place":["Houston, TX, United States"]},{"name":"Department of Pathology and Genomic Medicine, Houston Methodist Hospital","place":["Houston, TX, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica S.","family":"Thomas","sequence":"additional","affiliation":[{"name":"Cockrell Center Phase 1 Unit, Cockrell Center for Advanced Therapeutics, Houston Methodist Hospital","place":["Houston, TX, United States"]},{"name":"Department of Pathology and Genomic Medicine, Houston Methodist Hospital","place":["Houston, TX, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall J.","family":"Olsen","sequence":"additional","affiliation":[{"name":"Cockrell Center Phase 1 Unit, Cockrell Center for Advanced Therapeutics, Houston Methodist Hospital","place":["Houston, TX, United States"]},{"name":"Department of Pathology and Genomic Medicine, Houston Methodist Hospital","place":["Houston, TX, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda W.","family":"Moore","sequence":"additional","affiliation":[{"name":"Department of Surgery, Houston Methodist Hospital","place":["Houston, TX, United States"]},{"name":"Department of Surgery, Weill Cornell Medical College","place":["New York, NY, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirk","family":"Heyne","sequence":"additional","affiliation":[{"name":"Department of Medicine, Weill Cornell Medical College","place":["New York, NY, United States"]},{"name":"Department of Medical Oncology, Houston Methodist Cancer Center","place":["Houston, TX, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian C.","family":"Li","sequence":"additional","affiliation":[{"name":"JC Walter Jr Transplant Center, Houston Methodist Hospital","place":["Houston, TX, United States"]},{"name":"Department of Surgery, Weill Cornell Medical College","place":["New York, NY, United States"]},{"name":"Immunobiology and Transplant Science Center, Houston Methodist Research Institute, Houston Methodist Hospital","place":["Houston, TX, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"David W.","family":"Victor","sequence":"additional","affiliation":[{"name":"JC Walter Jr Transplant Center, Houston Methodist Hospital","place":["Houston, TX, United States"]},{"name":"Sherrie and Alan Conover Center for Liver Disease and Transplantation, Houston Methodist Hospital","place":["Houston, TX, United States"]},{"name":"Department of Medicine, Weill Cornell Medical College","place":["New York, NY, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy E.","family":"Newhook","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center","place":["Houston, TX, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed O.","family":"Kaseb","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center","place":["Houston, TX, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Nicolas","family":"Vauthey","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center","place":["Houston, TX, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Osama","family":"Gaber","sequence":"additional","affiliation":[{"name":"Department of Surgery, Houston Methodist Hospital","place":["Houston, TX, United States"]},{"name":"JC Walter Jr Transplant Center, Houston Methodist Hospital","place":["Houston, TX, United States"]},{"name":"Department of Surgery, Weill Cornell Medical College","place":["New York, NY, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Mark","family":"Ghobrial","sequence":"additional","affiliation":[{"name":"Department of Surgery, Houston Methodist Hospital","place":["Houston, TX, United States"]},{"name":"JC Walter Jr Transplant Center, Houston Methodist Hospital","place":["Houston, TX, United States"]},{"name":"Department of Surgery, Weill Cornell Medical College","place":["New York, NY, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","article-title":"Comprehensive and integrative genomic characterization of hepatocellular carcinoma","volume":"169","year":"2017","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B4","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/TP.0000000000002835.","article-title":"Outcomes of liver transplantation for hepatocellular carcinoma beyond the university of California San Francisco criteria: a single-center experience","volume":"104","author":"Victor","year":"2020","journal-title":"Transplantation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/SLA.0000000000001384","article-title":"Complete pathologic response to pretransplant locoregional therapy for hepatocellular carcinoma defines cancer cure after liver transplantation: analysis of 501 consecutively treated patients","volume":"262","author":"Agopian","year":"2015","journal-title":"Ann Surg"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1245\/s10434-011-1803-3","article-title":"Locoregional therapy-induced tumor necrosis as a predictor of recurrence after liver transplant in patients with hepatocellular carcinoma","volume":"18","author":"Ho","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/lt.25333","article-title":"The mRECIST classification provides insight into tumor biology for patients with hepatocellular carcinoma awaiting liver transplantation","volume":"25","author":"Lee","year":"2019","journal-title":"Liver Transpl"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1002\/hep.27198","article-title":"Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification","volume":"60","author":"Ahn","year":"2014","journal-title":"Hepatology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/hep.21467","article-title":"Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets","volume":"45","author":"Boyault","year":"2007","journal-title":"Hepatology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-024-07054-3","article-title":"Deep whole-genome analysis of 494 hepatocellular carcinomas","volume":"627","author":"Chen","year":"2024","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1002\/hep.26540","article-title":"Identification of driver genes in hepatocellular carcinoma by exome sequencing","volume":"58","author":"Cleary","year":"2013","journal-title":"Hepatology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/ng.2291","article-title":"Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators","volume":"44","author":"Fujimoto","year":"2012","journal-title":"Nat Genet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/ng.2256","article-title":"Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma","volume":"44","author":"Guichard","year":"2012","journal-title":"Nat Genet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/ng.2391","article-title":"Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma","volume":"44","author":"Huang","year":"2012","journal-title":"Nat Genet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1101\/gr.154492.113","article-title":"Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma","volume":"23","author":"Kan","year":"2013","journal-title":"Genome Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/hep.20375","article-title":"Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling","volume":"40","author":"Lee","year":"2004","journal-title":"Hepatology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/ng.3252","article-title":"Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets","volume":"47","author":"Schulze","year":"2015","journal-title":"Nat Genet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/ng.3126","article-title":"Trans-ancestry mutational landscape of hepatocellular carcinoma genomes","volume":"46","author":"Totoki","year":"2014","journal-title":"Nat Genet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1158\/1078-0432.CCR-18-2293","article-title":"Prospective genotyping of hepatocellular carcinoma: clinical implications of next-generation sequencing for matching patients to targeted and immune therapies","volume":"25","author":"Harding","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1159\/000504548","article-title":"Gene signature for sorafenib susceptibility in hepatocellular carcinoma: different approach with a predictive biomarker","volume":"9","author":"Kim","year":"2020","journal-title":"Liver Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/s41591-022-01868-2","article-title":"Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma","volume":"28","author":"Zhu","year":"2022","journal-title":"Nat Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jamcollsurg.2021.05.027","article-title":"Genomic sequencing and insight into clinical heterogeneity and prognostic pathway genes in patients with metastatic colorectal cancer","volume":"233","author":"Kawaguchi","year":"2021","journal-title":"J Am Coll Surg"},{"key":"B25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4103\/jpi.jpi_48_17","article-title":"Houston Methodist variant viewer: an application to support clinical laboratory interpretation of next-generation sequencing data for cancer","volume":"8","author":"Christensen","year":"2017","journal-title":"J Pathol Inform"},{"key":"B26","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/jamiaopen\/ooaa004","article-title":"Development and validation of Houston methodist variant viewer version 3: updates to our application for interpretation of next-generation sequencing data","volume":"3","author":"Christensen","year":"2020","journal-title":"JAMIA Open"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1056\/NEJMp1607591","article-title":"Toward a shared vision for cancer genomic data","volume":"375","author":"Grossman","year":"2016","journal-title":"N Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"PO.17.00011","DOI":"10.1200\/PO.17.00011","article-title":"OncoKB: a precision oncology knowledge base","volume":"2017","author":"Chakravarty","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","article-title":"Oncogenic signaling pathways in the cancer genome atlas","volume":"173","author":"Sanchez-Vega","year":"2018","journal-title":"Cell"},{"key":"B30","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"B31","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"B32","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/hep.31327","article-title":"Trial design and endpoints in hepatocellular carcinoma: aASLD consensus conference","volume":"73","author":"Llovet","year":"2021","journal-title":"Hepatology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1158\/0008-5472.CAN-09-2823","article-title":"Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma","volume":"70","author":"Woo","year":"2010","journal-title":"Cancer Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1053\/j.gastro.2017.06.007","article-title":"Identification of an immune-specific class of hepatocellular carcinoma, based on molecular features","volume":"153","author":"Sia","year":"2017","journal-title":"Gastroenterology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"B37","doi-asserted-by":"publisher","first-page":"7385","DOI":"10.1158\/0008-5472.CAN-09-1089","article-title":"Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma","volume":"69","author":"Hoshida","year":"2009","journal-title":"Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/jnci\/djr545","article-title":"A three-gene model to robustly identify breast cancer molecular subtypes","volume":"104","author":"Haibe-Kains","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1158\/1078-0432.CCR-17-2994","article-title":"Genomics-driven precision medicine for advanced pancreatic cancer: early results from the COMPASS trial","volume":"24","author":"Aung","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1080\/17474124.2017.1324296","article-title":"Next generation sequencing of pancreatic ductal adenocarcinoma: right or wrong?","volume":"11","author":"Connor","year":"2017","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41575-019-0229-4","article-title":"Tumour evolution in hepatocellular carcinoma","volume":"17","author":"Craig","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jamcollsurg.2014.12.025","article-title":"A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients","volume":"220","author":"Agopian","year":"2015","journal-title":"J Am Coll Surg"},{"key":"B43","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/SLA.0000000000001966","article-title":"Recurrence after liver transplantation for hepatocellular carcinoma: a new MORAL to the story","volume":"265","author":"Halazun","year":"2017","journal-title":"Ann Surg"},{"key":"B44","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1001\/jamaoncol.2016.5116","article-title":"Validation of a risk estimation of tumor recurrence after transplant (RETREAT) score for hepatocellular carcinoma recurrence after liver transplant","volume":"3","author":"Mehta","year":"2017","journal-title":"JAMA Oncol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD Practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1101\/gr.133926.111","article-title":"The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients","volume":"22","author":"Jiang","year":"2012","journal-title":"Genome Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"792781","DOI":"10.3389\/fimmu.2021.792781","article-title":"Combination of ablation and immunotherapy for hepatocellular carcinoma: where we are and where to go","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1038\/s41423-025-01308-4","article-title":"Immune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapy","volume":"22","author":"Seyhan","year":"2025","journal-title":"Cell Mol Immunol"}],"container-title":["Frontiers in Transplantation"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frtra.2026.1758576\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T06:01:26Z","timestamp":1775800886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frtra.2026.1758576\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":48,"alternative-id":["10.3389\/frtra.2026.1758576"],"URL":"https:\/\/doi.org\/10.3389\/frtra.2026.1758576","relation":{},"ISSN":["2813-2440"],"issn-type":[{"value":"2813-2440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"article-number":"1758576"}}